Results 41 to 50 of about 14,197,112 (305)

Social Functioning Within the First Years After Pediatric Brain Tumor Diagnosis and the Relationship With Family Psychosocial Risk

Pediatric Blood &Cancer, EarlyView.
ABSTRACT Background Survivors of pediatric brain tumors (PBTs) can experience long‐term social difficulties, impacting quality of life. Beyond medical and environmental factors, family psychosocial risk may play a role in social outcomes by shaping the caregiving environment and may provide intervention options.
Renske H. Houben, Marisa H. Huisman, Martha A. Grootenhuis, Femke K. Aarsen, Marita Partanen   +4 more
wiley   +1 more source

Late effects of cancer treatment:shared care [PDF]

, 2013
Many adverse effects of cancer treatment develop years after treatment completion. Late effects such as cardiotoxicity, metabolic syndrome, and osteoporosis can sometimes be prevented or reduced if they are detected early.
Bunskoek, Sophie, Siesling, Sabine, Berendsen, Annette, Gietema, Jourik, Nuver, Janine; id_orcid, Boer, Hink   +5 more
core   +1 more source

A structural equation modeling framework for estimating symptom burden based on symptom clusters in cancer survivors

Scientific Reports
Symptoms after cancer and its treatment challenge the well-being of cancer survivors. Little is known about symptom co-occurrence and the burden experienced by cancer survivors.
Anne Katrine Graudal Levinsen, Anders Tolver, Trille Kristina Kjaer, Lau Caspar Thygesen, Jan Wohlfahrt, Susanne Rosthøj, Lærke Kjær Tolstrup, Marianne Nord Hansen, Simone Oerlemans, Christine Miaskowski, Peer Christiansen, Peter Christensen, Christoffer Johansen, Robert Zachariae, Lena Saltbæk, Susanne Oksbjerg Dalton   +15 more
doaj   +1 more source

Retrospective Analysis of Donor Lymphocyte Infusions in Pediatric Patients With Mixed Chimerism After Hematopoietic Stem Cell Transplantation

Pediatric Blood &Cancer, EarlyView.
ABSTRACT Background Allogeneic hematopoietic stem cell transplantation (alloHSCT) is an essential therapy for several malignant and nonmalignant diseases, but relapse and graft loss remain the principal threats to its success. Routine monitoring of chimerism and minimal residual disease (MRD) enables early detection of imminent recurrence and guides ...
Carmen Junk, Sebastian Michaelis, Michaela Döring, Thomas Eichholz, Ursula Holzer, Martin Ebinger, Tim Flaadt, Rupert Handgretinger, Peter Lang, Jan Frederic Weller, Markus Mezger   +10 more
wiley   +1 more source

EORTC/RTOG Late Effects Grade Detail.

, 2014
EORTC/RTOG Late Effects Grade Detail.
Stanley L. Liauw (507756), Gene-Fu F. Liu (507754), Eric Bair (55923), Ryan J. Bair (507755), Matthew Koshy (460252)   +4 more
core   +1 more source

Secondary myeloid neoplasms after CD19 CAR T therapy in patients with refractory/relapsed B-cell lymphoma: Case series and review of literature

Frontiers in Immunology, 2023
BackgroundSeveral chimeric antigen receptor T cells (CAR T) targeting CD19 have induced profound and prolonged remission for refractory/relapsed (R/R) B-cell lymphoma.
Aiqi Zhao, Mingzhe Zhao, Wenbin Qian, Aibin Liang, Ping Li, Hui Liu   +5 more
doaj   +1 more source

Language, Culture, and Cancer: Qualitative Insights Into Communication Disparities Among Spanish‐Speaking Caregivers of Children With Cancer

Pediatric Blood &Cancer, EarlyView.
ABSTRACT Background Latino children are projected to make up nearly one‐third of United States (US) children by 2060, and many of their caregivers speak Spanish. Prior survey research has documented communication difficulties for Spanish‐speaking caregivers of children with cancer, but contemporary qualitative data are limited.
Jenny Ruiz, Alejandra Curbelo‐Paz, Sonia Morales, Elizabeth Contreras, Amy Houtrow, Scott H. Maurer, Judy C. Chang   +6 more
wiley   +1 more source

Late effects from hadron therapy [PDF]

, 2004
Successful cancer patient survival and local tumor control from hadron radiotherapy warrant a discussion of potential secondary late effects from the radiation.
Chang, Polly Y., Blakely, Eleanor A.
core  

Examining the efficacy of treatments for arm lymphedema in breast cancer survivors: an overview of systematic reviews with meta-analysesResearch in context

EClinicalMedicine
Summary: Background: Lymphedema affects one in six breast cancer survivors making it a global healthcare challenge. There is considerable debate about the efficacy of different treatments for lymphedema.
Bolette Skjødt Rafn, Anne Bodilsen, Annika von Heymann, Maja Johannsen Lindberg, Sofia Byllov, Tine Ginnerup Andreasen, Christoffer Johansen, Peer Christiansen, Robert Zachariae   +8 more
doaj   +1 more source

Biphasic Clinical Course of Pediatric Cytomegalovirus‐Associated Immune Thrombocytopenia: Early Poor Treatment Response but Favorable Long‐Term Outcomes

Pediatric Blood &Cancer, EarlyView.
ABSTRACT Background Cytomegalovirus (CMV) is a recognized trigger of immune thrombocytopenia (ITP); however, its incidence and impact on disease course in children remain controversial. Therefore, we aimed to characterize the clinical course of pediatric patients with CMV‐associated ITP.
Oded Gilad, Ohad Atia, Osama Tanous, Dafna Brik Simon, Michal Dvori, Miriam Cohen, Tracie A. Goldberg, Efraim Bilavsky, Joanne Yacobovich, Orna Steinberg‐Shemer   +9 more
wiley   +1 more source